Last reviewed · How we verify

perineural dexamethasone

Poznan University of Medical Sciences · FDA-approved active Small molecule

perineural dexamethasone is a Corticosteroid Small molecule drug developed by Poznan University of Medical Sciences. It is currently FDA-approved for Prolongation of peripheral nerve blocks and regional anesthesia, Postoperative pain management. Also known as: Dexamethasone Sodium Phosphate Injection, Nerve block with local anesthetic and dexamethasone, Decoin.

Perineural dexamethasone is a corticosteroid administered adjacent to a nerve to reduce inflammation and prolong the duration of regional anesthesia.

Perineural dexamethasone is a corticosteroid administered adjacent to a nerve to reduce inflammation and prolong the duration of regional anesthesia. Used for Prolongation of peripheral nerve blocks and regional anesthesia, Postoperative pain management.

At a glance

Generic nameperineural dexamethasone
Also known asDexamethasone Sodium Phosphate Injection, Nerve block with local anesthetic and dexamethasone, Decoin
SponsorPoznan University of Medical Sciences
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaAnesthesia / Pain Management
PhaseFDA-approved

Mechanism of action

Dexamethasone, a potent glucocorticoid, suppresses local inflammatory responses when deposited in the perineural space around a nerve. This anti-inflammatory action reduces edema and nerve irritation, thereby extending the analgesic duration of local anesthetic blocks. The mechanism involves inhibition of phospholipase A2 and reduction of prostaglandin and cytokine production at the injection site.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about perineural dexamethasone

What is perineural dexamethasone?

perineural dexamethasone is a Corticosteroid drug developed by Poznan University of Medical Sciences, indicated for Prolongation of peripheral nerve blocks and regional anesthesia, Postoperative pain management.

How does perineural dexamethasone work?

Perineural dexamethasone is a corticosteroid administered adjacent to a nerve to reduce inflammation and prolong the duration of regional anesthesia.

What is perineural dexamethasone used for?

perineural dexamethasone is indicated for Prolongation of peripheral nerve blocks and regional anesthesia, Postoperative pain management.

Who makes perineural dexamethasone?

perineural dexamethasone is developed and marketed by Poznan University of Medical Sciences (see full Poznan University of Medical Sciences pipeline at /company/poznan-university-of-medical-sciences).

Is perineural dexamethasone also known as anything else?

perineural dexamethasone is also known as Dexamethasone Sodium Phosphate Injection, Nerve block with local anesthetic and dexamethasone, Decoin.

What drug class is perineural dexamethasone in?

perineural dexamethasone belongs to the Corticosteroid class. See all Corticosteroid drugs at /class/corticosteroid.

What development phase is perineural dexamethasone in?

perineural dexamethasone is FDA-approved (marketed).

What are the side effects of perineural dexamethasone?

Common side effects of perineural dexamethasone include Hyperglycemia, Local tissue irritation, Infection risk (with repeated use).

What does perineural dexamethasone target?

perineural dexamethasone targets Glucocorticoid receptor and is a Corticosteroid.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing